Search results
Duchenne approval exposes FDA rift over Sarepta gene therapy
BioPharma Dive via Yahoo Finance· 3 days agoPeter Marks’ decision to override the objections of agency staff and broaden use of Elevidys could...
James Morrison's poignant last message before fiancée Gill's tragic death
Daily Mirror· 3 days agoJames Morrison's ex-fiancée Gill Catchpole tragically took her own life after being in a 'difficult...
In Letters, Gabby Petito Urged Brian Laundrie to 'Stop Crying.' Expert Says Notes Reflect Toxic...
People Magazine· 3 days agoAn expert says these letters are evidence of Laundrie’s manipulative behavior. The letters were ...
Deep learning shows promise for soft tissue sarcoma management
Medical Xpress· 4 days agoSoft tissue sarcomas (STSs) represent a diverse group of tumors that pose significant diagnostic and therapeutic challenges. In a recent review published in the journal Meta-Radiology ...
Man charged with killing therapy service dog in Norwood Young America
KMSP via Yahoo News· 3 days ago(FOX 9) - A 55-year-old man has been arrested and charged in the fatal shooting of a family's ...
FDA’s Sarepta decision could represent ‘new way of thinking’ for agency - Boston Business Journal
The Business Journals· 14 hours agoThe U.S. Food and Drug Administration’s recent decision to expand approval for a Cambridge company’s controversial gene therapy could signal a changing approach to how the ...
‘Crooked Smile’ Review: When Trouble Leaves a Mark
The Wall Street Journal· 17 hours agoHe begins with drinking and smoking pot in his teens. He goes to live with an aunt and uncle in California after his mother dies of an overdose and tries...
FDA lifts hold on PTC Huntington’s disease trial
BioPharma Dive via Yahoo Finance· 4 days agoThat compares with a 1-point improvement for people who got the UniQure gene therapy, analysts wrote. However, PTC518 didn’t appear to have any impact on...
Sarepta Duchenne gene therapy wins broader use from FDA
BioPharma Dive via Yahoo Finance· 4 days agoThe approval makes Elevidys available to most Duchenne patients at least 4 years of age, despite...
uniQure director Balachandran Madhavan sells shares worth over $11k By Investing.com
Investing.com· 6 days agoIn a recent transaction, uniQure N.V. (NASDAQ:QURE) Director Balachandran Madhavan sold 2,231 shares...
